Premium
Tumor‐Exocytosed Exosome/Aggregation‐Induced Emission Luminogen Hybrid Nanovesicles Facilitate Efficient Tumor Penetration and Photodynamic Therapy
Author(s) -
Zhu Daoming,
Duo Yanhong,
Suo Meng,
Zhao Yonghua,
Xia Ligang,
Zheng Zheng,
Li Yang,
Tang Ben Zhong
Publication year - 2020
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.202003672
Subject(s) - photodynamic therapy , exosome , tumor microenvironment , penetration (warfare) , microvesicles , chemistry , photosensitizer , aggregation induced emission , cancer research , biophysics , nanotechnology , materials science , tumor cells , medicine , biochemistry , biology , microrna , fluorescence , optics , physics , organic chemistry , operations research , engineering , gene
The development of novel photosensitizing agents with aggregation‐induced emission (AIE) properties has fueled significant advances in the field of photodynamic therapy (PDT). An electroporation method was used to prepare tumor‐exocytosed exosome/AIE luminogen (AIEgen) hybrid nanovesicles (DES) that could facilitate efficient tumor penetration. Dexamethasone was then used to normalize vascular function within the tumor microenvironment (TME) to reduce local hypoxia, thereby significantly enhancing the PDT efficacy of DES nanovesicles, and allowing them to effectively inhibit tumor growth. The hybridization of AIEgen and biological tumor‐exocytosed exosomes was achieved for the first time, and combined with PDT approaches by normalizing the intratumoral vasculature as a means of reducing local tissue hypoxia. This work highlights a new approach to the design of AIEgen‐based PDT systems and underscores the potential clinical value of AIEgens.